These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27534254)

  • 21. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Gatto L; Alfano G; Miglionico M; Covino E; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):795-800. PubMed ID: 20613550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitavastatin - from clinical trials to clinical practice.
    Masana L
    Atheroscler Suppl; 2010 Dec; 11(3):15-22. PubMed ID: 21193154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia.
    Baker WL; Datta R
    Adv Ther; 2011 Jan; 28(1):13-27. PubMed ID: 21170619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration of statins during the acute phase of acute coronary syndrome].
    Ruiz-Bailén M
    Med Intensiva; 2010; 34(1):56-63. PubMed ID: 19875196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statins according to individual risk].
    Füessl HS; Stiefelhagen P
    MMW Fortschr Med; 2016 Mar; 158(6):35. PubMed ID: 27084146
    [No Abstract]   [Full Text] [Related]  

  • 28. Pitavastatin: a new HMG-CoA reductase inhibitor.
    Wensel TM; Waldrop BA; Wensel B
    Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin - results from phase III & IV.
    Betteridge J
    Atheroscler Suppl; 2010 Dec; 11(3):8-14. PubMed ID: 21193153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease.
    Kurata T; Miyazaki K; Morimoto N; Kawai H; Ohta Y; Ikeda Y; Abe K
    Neurol Res; 2013 Mar; 35(2):193-205. PubMed ID: 23336815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The PRATO-ACS study].
    Marenzi G; Briguori C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
    [No Abstract]   [Full Text] [Related]  

  • 34. Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.
    Barrios V; Escobar C; Zamorano JL
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1597-612. PubMed ID: 24215190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of statin administration in acute coronary syndromes.
    Papageorgiou N; Tousoulis D; Antoniades C; Giolis A; Briasoulis A; Stefanadis C
    Hellenic J Cardiol; 2010; 51(3):250-61. PubMed ID: 20515858
    [No Abstract]   [Full Text] [Related]  

  • 36. [Statins in the management of acute coronary syndrome].
    Matoba T; Egashira K
    Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Author's Reply.
    Aydın U; Ata Y; Türk T
    Anatol J Cardiol; 2015 Oct; 15(10):857-8. PubMed ID: 26828081
    [No Abstract]   [Full Text] [Related]  

  • 38. Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.
    Waters DD; Ku I
    J Am Coll Cardiol; 2009 Oct; 54(15):1434-7. PubMed ID: 19796736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation after cardiac surgery.
    İşcan Ş; Yürekli İ; Çakır H; Peker İ; Kestelli M
    Anatol J Cardiol; 2015 Oct; 15(10):856-7. PubMed ID: 26477730
    [No Abstract]   [Full Text] [Related]  

  • 40. Pitavastatin.
    Mukhtar RY; Reid J; Reckless JP
    Int J Clin Pract; 2005 Feb; 59(2):239-52. PubMed ID: 15854203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.